Literature DB >> 915290

Partial purification of human lymphocyte-activating factor (LAF) by ultrafiltration and electrophoretic techniques.

L B Lachman, M P Hacker, R E Handschumacher.   

Abstract

Lymphocyte-activating factor (LAF) has been produced by culturing human peripheral blood leukocytes in the presence of lipopolysaccharide and autologous human serum. The major LAF activity, identifiable by Sephadex chromatography (m.w. 13,000) was separated from most serum proteins in the culture medium by ultrafiltration with a hollow fiber device. Sucrose gradient isoelectric focusing of the concentrated ultrafiltrate yielded a single peak of LAF activity with an average isoelectric point of pH 6.8. Semi-preparative polyacrylamide gel electrophoresis of the isoelectric focusing sample resulted in separation of the LAF activity from detectable amounts of serum proteins. The recovered LAF activity was estimated to be purified more than 16,000-fold and is judged to be active in submicrogram amounts.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915290

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  The molecular forms of interleukin-1.

Authors:  T P Hopp; S K Dower; C J March
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

2.  T3 expression by human thymocytes in culture.

Authors:  F B Aiello; P Musiani; N Maggiano; L M Larocca; M Piantelli
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

3.  Regulation of T-cell function by antibodies: enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies.

Authors:  E Celis; V R Zurawski; T W Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

5.  Glucocorticoid inhibitory action on the response to PHA of residual circulatory lymphocytes in renal transplant patients following immunosuppressive therapy.

Authors:  P Musiani; F Citterio; N Maggiano; U Pozzetto; L Lauriola; G Luciani; F O Ranelletti; M Castagneto; M Piantelli
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

6.  Modulation of human mononuclear cell responses by neutrophil-derived factors. II. Partial characterization of a neutrophil-derived lymphocyte-enhancing factor (N-LEF).

Authors:  R S Panush
Journal:  Inflammation       Date:  1983-03       Impact factor: 4.092

7.  Human thymoma lymphocyte mitogenesis: glucocorticoid inhibitory capacity as a function of the size of the more mature T cell subset.

Authors:  L Lauriola; P Musiani; F O Ranelletti; N Maggiano; M Piantelli
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

8.  Characterization of proteins from human synovium and mononuclear leucocytes that induce resorption of cartilage proteoglycan in vitro.

Authors:  J Saklatvala; S J Sarsfield; L M Pilsworth
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

9.  Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; A Laffon; D Alarcón-Segovia
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

10.  Defective monokine production and decreased responsiveness of polymorphonuclear leukocytes to recombinant interleukin-1 in asthmatic patients.

Authors:  K H Hsieh; K H Lue
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.